Pharmacologic Prevention of Microvascular and Macrovascular Complications in Diabetes Mellitus: Implications of the Results of Recent Clinical Trials in Type 2 Diabetes

By Tandon Nikhil  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 1, 2012-02 ,pp. : 7-22

Adis International

Access to resources Recommend Favorite

Influence of Intensive versus Conventional Glucose Control on Microvascular and Macrovascular Complications in Type 1 and 2 Diabetes Mellitus

By Mattila Taina K.   >  

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2229-2245

Adis International

Access to resources Recommend Favorite

Economic Outcomes Associated with Switching Individuals with Schizophrenia Between Risperidone and Olanzapine: Findings from a Large US Claims Database

By Zhao Z.   Namjoshi M.   Barber B.L.   Loosbrock D.L.   Tunis S.L.   Zhu B.   Breier A.  

CNS Drugs, Vol. 18, Iss. 3, 2004-01 ,pp. : 157-164

Adis International

Access to resources Recommend Favorite

Kalpaamruthaa ameliorates myocardial and aortic damage in cardiovascular complications associated with type 2 diabetes mellitus

By Shanthi Palanivelu   Sachdanandam Panchanadham  

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 2, 2012-11 ,pp. : 116-123

NRC Research Press

Access to resources Recommend Favorite

Which Musculoskeletal Complications Are Most Frequently Seen in Type 2 Diabetes Mellitus?

By Aydeniz A   Gursoy S   Guney E  

The Journal of International Medical Research, Vol. 36, Iss. 3, 2008-05 ,pp. : 505-511

Field House Publishing

Access to resources Recommend Favorite